Medical Cannabis as a Substitute for Prescription Agents: A Systematic Review and Meta-analysis

References

• Abuhasira, R., Schleider, L. B., Mechoulam, R., & Novack, V. (2018). Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. European Journal of Internal Medicine, 49, 44–50. https://doi.org/10.1016/j.ejim.2018.01.019
   PubMed Web of Science ®Google Scholar
• Bachhuber, M., Arnsten, J. H., & Wurm, G. (2019). Use of cannabis to relieve pain and promote sleep by customers at an adult use dispensary. Journal of Psychoactive Drugs, 51(5), 400–404. https://doi.org/10.1080/02791072.2019.1626953
   PubMed Web of Science ®Google Scholar
• Barlowe, T. S., Koliani-Pace, J. L., Smith, K. D., Gordon, S. R., & Gardner, T. B. (2019). Effects of medical cannabis on use of opioids and hospital visits by patients with painful chronic pancreatitis. Clinical Gastroenterology and Hepatology, 17(12), 2608–2609. https://doi.org/10.1016/j.cgh.2019.01.018
   PubMed Web of Science ®Google Scholar
• Baron, E. P., Lucas, P., Eades, J., & Hogue, O. (2018). Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. Journal of Headache and Pain, 19(1), 37. https://doi.org/10.1186/s10194-018-0862-2
   PubMedGoogle Scholar
• Boehnke, K. F., Litinas, E., & Clauw, D. J. (2016). Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. Journal of Pain, 17(6), 739–744. https://doi.org/10.1016/j.jpain.2016.03.002
   PubMed Web of Science ®Google Scholar
• Boehnke, K. F., Scott, J. R., Litinas, E., Sisley, S., Williams, D. A., & Clauw, D. J. (2019). Pills to pot: Observational analyses of cannabis substitution among medical cannabis users with chronic pain. Journal of Pain, 20(7), 830–841. https://doi.org/10.1016/j.jpain.2019.01.010
   PubMed Web of Science ®Google Scholar
• Bradford, A. C., & Bradford, W. D. (2016). Medical Marijuana laws reduce prescription medication use in medicare part D. Health Affairs (Millwood), 35(7), 1230–1236. https://doi.org/10.1377/hlthaff.2015.1661
   PubMed Web of Science ®Google Scholar
• Cameron, C., Watson, D., & Robinson, J. (2014). Use of a synthetic cannabinoid in a correctional population for PTSD related insomnia and nightmares, chronic pain, harm reduction and other indications: A retrospective evaluation. Journal of Clinical Psychopharmacology, 34(5), 559–564. https://doi.org/10.1097/JCP.0000000000000180
   Web of Science ®Google Scholar
• Campbell, G., Hall, W. D., Peacock, A., Lintzeris, N., Bruno, R., Larance, B., Nielsen, S., Cohen, M., Chan, G., Mattick, R. P., Blyth, F., Shanahan, M., Dobbins, T., Farrell, M., & Degenhardt, L. (2018). Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: Findings from a 4-year prospective cohort study. Lancet Public Health, 3(7), e341–e350. https://doi.org/10.1016/S2468-2667(18)30110-5
   PubMed Web of Science ®Google Scholar
• Caputi, T. L., & Humphreys, K. (2018). Medical Marijuana users are more likely to use prescription drugs medically and nonmedically. Journal of Addiction Medicine, 12(4), 295–299. https://doi.org/10.1097/ADM.0000000000000405
   PubMed Web of Science ®Google Scholar
• Carlini, E. A. (2004). The good and the bad effects of (-) trans-delta-9-tetrahydrocannabinol (Delta 9-THC) on humans. Toxicon, 44(4), 461–467. https://doi.org/10.1016/j.toxicon.2004.05.009
   PubMed Web of Science ®Google Scholar
• Charernboon, T., Lerthattasilp, T., & Supasitthumrong, T. (2021). Effectiveness of cannabinoids for treatment of dementia: A systematic review of randomized controlled trials. Clinical Gerontologist, 44(1), 16–24. https://doi.org/10.1080/07317115.2020.1742832
   PubMed Web of Science ®Google Scholar
• Corroon, J., Mischley, L., & Sexton, M. (2017). Cannabis as a substitute for prescription drugs – A cross-sectional study. Journal of Pain Research, 10, 989–998. https://doi.org/10.2147/jpr.S134330
   PubMed Web of Science ®Google Scholar
• Decorte, T., Lenton, S., & Wilkins, C. (2020). Legalizing cannabis: Experiences, lessons and scenarios. Routledge.
   Google Scholar
• Fischer, B., Murphy, Y., Kurdyak, P., Goldner, E., & Rehm, J. (2015). Medical marijuana programs - Why might they matter for public health and why should we better understand their impacts? Preventive Medicine Reports, 2, 53–56. https://doi.org/10.1016/j.pmedr.2014.12.006
   PubMedGoogle Scholar
• Haroutounian, S., Ratz, Y., Ginosar, Y., Furmanov, K., Saifi, F., Meidan, R., & Davidson, E. (2016). The effect of medicinal cannabis on pain and quality-of-life outcomes in chronic pain: A prospective open-label study. Clinical Journal of Pain, 32(12), 1036–1043. https://doi.org/10.1097/AJP.0000000000000364
   PubMed Web of Science ®Google Scholar
• Ishida, J. H., Wong, P. O., Cohen, B. E., Vali, M., Steigerwald, S., & Keyhani, S. (2019). Substitution of marijuana for opioids in a national survey of US adults. PLoS One, 14(10), e0222577. https://doi.org/10.1371/journal.pone.0222577
   PubMed Web of Science ®Google Scholar
• Joanna Briggs Institute. (2017). JBI critical appraisal checklist for studies reporting prevalence data. University of Adelaide.
   Google Scholar
• Lucas, P., Baron, E. P., & Jikomes, N. (2019). Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients. Harm Reduction Journal, 16(1), 9. https://doi.org/10.1186/s12954-019-0278-6
   PubMed Web of Science ®Google Scholar
• Lucas, P., Reiman, A., Earleywine, M., McGowan, S. K., Oleson, M., Coward, M. P., & Thomas, B. (2013). Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients. Addiction Research & Theory, 21(5), 435–442. https://doi.org/10.3109/16066359.2012.733465
   Web of Science ®Google Scholar
• Lucas, P., & Walsh, Z. (2017). Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. International Journal of Drug Policy, 42, 30–35. https://doi.org/10.1016/j.drugpo.2017.01.011
   PubMed Web of Science ®Google Scholar
• Lucas, P., Walsh, Z., Crosby, K., Callaway, R., Belle-Isle, L., Kay, R., Capler, R., & Holtzman, S. (2016). Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors. Drug and Alcohol Review, 35(3), 326–333. https://doi.org/10.1111/dar.12323
   PubMed Web of Science ®Google Scholar
• Mechoulam, R., Parker, L. A., & Gallily, R. (2002). Cannabidiol: An overview of some pharmacological aspects. Journal of Clinical Pharmacology, 42(S1), 11S–19S. https://doi.org/10.1002/j.1552-4604.2002.tb05998.x
   PubMedGoogle Scholar
• Murnion, B. (2015). Medicinal cannabis. Australian Prescriber, 38(6), 212–215. https://doi.org/10.18773/austprescr.2015.072
   PubMed Web of Science ®Google Scholar
• National Academies of Sciences, Enginerring & Medicine. (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. The National Academies Press. https://doi.org/10.17226/24625
   Google Scholar
• O’Connell, M., Sandgren, M., Frantzen, L., Bower, E., & Erickson, B. (2019). Medical cannabis: Effects on opioid and benzodiazepine requirements for pain control. Annals of Pharmacotherapy, 53(11), 1081–1086. https://doi.org/10.1177/1060028019854221
   PubMed Web of Science ®Google Scholar
• Pini, L. A., Guerzoni, S., Cainazzo, M. M., Ferrari, A., Sarchielli, P., Tiraferri, I., Ciccarese, M., & Zappaterra, M. (2012). Nabilone for the treatment of medication overuse headache: Results of a preliminary double-blind, active-controlled, randomized trial. Journal of Headache and Pain, 13(8), 677–684. https://doi.org/10.1007/s10194-012-0490-1
   PubMed Web of Science ®Google Scholar
• Piper, B. J., DeKeuster, R. M., Beals, M. L., Cobb, C. M., Burchman, C. A., Perkinson, L., Lynn, S. T., Nichols, S. D., & Abess, A. T. (2017). Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep. Journal of Psychopharmacology, 31(5), 569–575. https://doi.org/10.1177/0269881117699616
   PubMed Web of Science ®Google Scholar
• Pratt, M., Stevens, A., Thuku, M., Butler, C., Skidmore, B., Wieland, L. S., Clemons, M., Kanji, S., & Hutton, B. (2019). Benefits and harms of medical cannabis: A scoping review of systematic reviews. Systematic Reviews, 8(1), 320. https://doi.org/10.1186/s13643-019-1243-x
   PubMed Web of Science ®Google Scholar
• Purcell, C., Davis, A., Moolman, N., & Taylor, S. M. (2019). Reduction of benzodiazepine use in patients prescribed medical cannabis. Cannabis and Cannabinoid Research, 4(3), 214–218. https://doi.org/10.1089/can.2018.0020
   PubMedGoogle Scholar
• Ransing, R., de la Rosa, P. A., Pereira-Sanchez, V., Handuleh, J. I., Jerotic, S., Gupta, A. K., & Jatchavala, C. (2021). Current state of cannabis use, policies, and research across sixteen countries: Cross-country comparisons and international perspectives. Trends in Psychiatry and Psychotherapy. Online ahead of print. https://doi.org/10.47626/2237-6089-2021-0263
   Google Scholar
• Reiman, A. (2007). Medical cannabis patients: Patient profiles and health care utilization patterns. Complementary Health Practice Review, 12(1), 31–50. https://doi.org/10.1177/1533210107301834
   Google Scholar
• Reiman, A. (2009). Cannabis as a substitute for alcohol and other drugs. Harm Reduction Journal, 6(1), 1–5. https://doi.org/10.1186/1477-7517-6-35
   PubMedGoogle Scholar
• Reiman, A., Welty, M., & Solomon, P. (2017). Cannabis as a substitute for opioid-based pain medication: Patient self-report. Cannabis and Cannabinoid Research, 2(1), 160–166. https://doi.org/10.1089/can.2017.0012
   PubMedGoogle Scholar
• Safakish, R., Ko, G., Salimpour, V., Hendin, B., Sohanpal, I., Loheswaran, G., & Yoon, S. Y. R. (2020). Medical cannabis for the management of pain and quality of life in chronic pain patients: a prospective observational study. Pain Medicine, 21(11), 3073–3086. https://doi.org/10.1093/pm/pnaa163
   PubMed Web of Science ®Google Scholar
• Sagy, I., Bar-Lev Schleider, L., Abu-Shakra, M., & Novack, V. (2019). Safety and efficacy of medical cannabis in fibromyalgia. Journal of Clinical Medicine, 8(6). 807. https://doi.org/10.3390/jcm8060807
   Google Scholar
• Schleider, -L. B.-L., Mechoulam, R., Lederman, V., Hilou, M., Lencovsky, O., Betzalel, O., Shbiro, L., & Novack, V. (2018). Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer. European Journal of Internal Medicine, 49, 37–43. https://doi.org/10.1016/j.ejim.2018.01.023
   PubMed Web of Science ®Google Scholar
• Siklos-Whillans, J., Bacchus, A., & Manwell, L. A. (2021). A scoping review of the use of cannabis and Its extracts as potential harm reduction strategies: Insights from preclinical and clinical research. International Journal of Mental Health and Addiction, 19, 1527–1550. https://doi.org/10.1007/s11469-020-00244-w
   Google Scholar
• Smith, J. M., Mader, J., Szeto, A. C., Arria, A. M., Winters, K. C., & Wilkes, T. C. R. (2019). Cannabis use for medicinal purposes among Canadian university students. Canadian Journal of Psychiatry, 64(5), 351–355. https://doi.org/10.1177/0706743718818420
   PubMed Web of Science ®Google Scholar
• Stockings, E., Zagic, D., Campbell, G., Wtaeier, M., Hall, W. D., Nielsen, S., Herkes, G. K., Farrell, M., & Degenhardt, L. (2018). Evidence for cannabis and cannabinoids for epilepsy: A systematic review of controlled and observational evidence. Journal of Neurology, Neurosurgery, and Psychiatry, 89(7), 741–753. https://doi.org/10.1136/jnnp-2017-317168
   PubMed Web of Science ®Google Scholar
• Subbaraman, M. S. (2014). Can cannabis be considered a substitute medication for alcohol? Alcohol Alcohol, 49(3), 292–298. https://doi.org/10.1093/alcalc/agt182
   PubMed Web of Science ®Google Scholar
• Turna, J., Simpson, W., Patterson, B., Lucas, P., & Van Ameringen, M. (2019). Cannabis use behaviors and prevalence of anxiety and depressive symptoms in a cohort of Canadian medicinal cannabis users. Journal of Psychiatric Research, 111, 134–139. https://doi.org/10.1016/j.jpsychires.2019.01.024
   PubMed Web of Science ®Google Scholar
• United Nations. (2020). World Drug Report.
   Google Scholar
• Vyas, M. B., LeBaron, V. T., & Gilson, A. M. (2018). The use of cannabis in response to the opioid crisis: A review of the literature. Nursing Outlook, 66(1), 56–65. https://doi.org/10.1016/j.outlook.2017.08.012
   PubMed Web of Science ®Google Scholar
• Walsh, Z., Gonzalez, R., Crosby, K., M, S. T., Carroll, C., & Bonn-Miller, M. O. (2017). Medical cannabis and mental health: A guided systematic review. Clinical Psychology Review, 51, 15–29. https://doi.org/10.1016/j.cpr.2016.10.002
   PubMed Web of Science ®Google Scholar
• Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., Keurentjes, J. C., Lang, S., Misso, K., Ryder, S., Schmidlkofer, S., Westwood, M., & Kleijnen, J. (2015). Cannabinoids for medical use: A systematic review and meta-analysis. JAMA, 313(24), 2456–2473. https://doi.org/10.1001/jama.2015.6358
   PubMed Web of Science ®Google Scholar
• Zuardi, A. W. (2006). History of cannabis as a medicine: A review. Brazilian Journal of Psychiatry, 28(2), 153–157. https://doi.org/10.1590/s1516-44462006000200015
   PubMed Web of Science ®Google Scholar